Résultats pour : cfo

European CFO Survey Q1 2016

17/05/2016
Welcome to the third Deloitte European CFO Survey, part of a global cohort of surveys benchmarking the current and future intentions of Chief Financial Officers.

Niall Donnelly nommé CFO de Cosmo

18/05/2016
Cosmo déménage son siège de Luxembourg à Dublin, nomme un nouveau CFO.

Canada | CFO Moves – week ending April 29, 2016

09/05/2016
Tracking CFO Movement Across Canada.

Stem Welcomes Chief Financial Officer Bill Bush

05/12/2016
Stem, Inc., the global leader in commercial-scale intelligent energy storage services, today announced Bill Bush as its new Chief Financial Officer, responsible for leading and expanding the company’s corporate and project financing efforts.

CEVA Logistics appoints Peter Waller as Chief Financial Officer

27/10/2016
CEVA Logistics, one of the world’s largest supply chain management companies, has today announced the appointment of Peter Waller as Chief Financial Officer and member of the Executive Board with immediate effect.

Progress Announces Appointment of Kurt J. Abkemeier as Chief Financial Officer

30/11/2016
Progress (NASDAQ:PRGS) today announced the appointment of Kurt J. Abkemeier as its new chief financial officer. As CFO, Abkemeier will oversee the company's global finance and accounting operations and be a member of the company's executive leadership team, reporting to Phil Pead, president and chief executive officer. Abkemeier succeeds Chris E. Perkins, who informed the company in March 2016 that he would retire as CFO upon the appointment of his successor. Abkemeier begins as CFO at Progress on September 28, 2016.

USA | CFO Moves – week ending May 6, 2016

12/05/2016
Tracking CFO Movement Across Canada.

USA | CFO Moves – week ending April 29, 2016

10/05/2016
Tracking CFO movement across the USA.

USA | CFO Moves – week ending April 22, 2016

04/05/2016
Tracking CFO movement across the USA.

OptiNose Appoints Keith Goldan as Chief Financial Officer

31/01/2017
OptiNose today announced the appointment of Keith A. Goldan as Chief Financial Officer (CFO). Mr. Goldan brings to the company more than 25 years of executive finance and operational leadership in biopharmaceutical and medical technology companies. He will be responsible for the financial leadership of the company, including investor relations, working to ensure the Company is properly capitalized with established controls for financial reporting.